Cyclerion Therapeutics (CYCN) Live Share Price, Invest From India

Cyclerion Therapeutics Stock Performance

as on September 9, 2026 at 2:15 pm IST

Day's Low
Day's High
$2.82
Day's Price Range
$3.75
$23.52
88.01%
Downside
-84.06%
Upside
52 Week's Low
52 Week's High
$1.03
52-Week Price Range
$8.48
$23.52
95.64%
Downside
-63.95%
Upside

Cyclerion Therapeutics share price movements today

Previous Close: $29.75
Open: $3.75
Volume: 984.0K
Market Cap: $19.9M
Day's Low - High: $2.82 - $3.75
52 Week Low - High: $1.03 - $8.48

Cyclerion Therapeutics Historical Returns

1 Month Return: + 19.05 %
3 Month Return: + 42.62 %
1 Year Return: + 91.85 %
3 Year Return: + 19.72 %
5 Year Return: -93.3 %

Cyclerion Therapeutics Stock Fundamentals & Key Indicators

Check Cyclerion Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.9M

EPS (TTM)

-1.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

EBITDA

-9.6M

Revenue (TTM)

1.9M

Profit Margin

0.00%

Return On Equity TTM

-98.22%

Cyclerion Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cyclerion Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cyclerion Therapeutics	Buy	$19.9M	-93.30%	NA	0.00%	0.00%
Revolution Medicines	StrongBuy	$41.0B	468.83%	-21.59	0.00%	0.00%
Vertex Pharmaceuticals	StrongBuy	$141.7B	192.56%	32.27	86.04%	0.00%
Moderna	Neutral	$88.5B	-36.16%	-27.78	-12.57%	0.00%
Regeneron	Buy	$95.5B	47.41%	19.76	85.77%	0.40%

Stock Returns calculator for Cyclerion Therapeutics Stock including INR - Dollar returns

The Cyclerion Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cyclerion Therapeutics investment value today

Current value as on today

₹11,33,703

Returns

₹10,33,703

(+1.03K%)

Returns from Cyclerion Therapeutics Stock

₹9,61,707 (+961.71%)

Dollar Impact

₹71,996 (+72%)

Analyst Recommendation on Cyclerion Therapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Cyclerion Therapeutics. Average target price of $8

Cyclerion Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Cyclerion Therapeutics.

What analysts predicted

-194%DOWNSIDE

Target Price

Current Price

$23.52

Analyzed by

7 Analysts

Target

$8.00

Cyclerion Therapeutics target price $8, a slight downside of -194% compared to current price of $23.52. According to 7 analysts rating.

Indian Investors' Interest in Cyclerion Therapeutics Stock

Search interest for Cyclerion Therapeutics Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 5, 2026 to November 4, 2026

Change:33% versus previous 30 day period

Cyclerion Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	0	1	0	0	0	1	-	-
Gross Profit	0	0	0	1	0	0	0	1	0	-
Operating Income	-1	-1	-1	0	-1	-1	-1	0	-3	-1
EBITDA	-1	-1	0	0	-1	0	0	0	-3	-1
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	-1	0	0	-1	0	0	0	-3	-1
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	0	0	-1	0	0	0	-3	-1
Net Profit Margin	0.00%	0.00%	-372.68%	29.35%	-1764.20%	-348.39%	-111.54%	-77.95%	0.00%	0.00%

Cyclerion Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	4	2	3	0	-	2	2
Gross Profit	-2	-1	-1	-90	-54	3	-5	-1	2	2
Operating Income	-63	-93	-115	-125	-81	-55	-18	-12	-3	-4
EBITDA	-61	-92	-113	-122	-80	-53	-18	-9	-3	-3
Interest Expense	-	-	-	-	0	0	0	-	-	-
Depreciation	-	1	1	2	2	0	0	-	-	-
Income Before Tax	-63	-93	-115	-123	-77	-51	-18	-12	-3	-3
Income Tax Expense	-	-	1	-2	-5	0	0	8	-	-
Net Income	-63	-93	-115	-123	-77	-51	-44	-5	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	-2729.27%	-3388.59%	-1555.63%	-14841.08%	0.00%	-152.85%	-170.11%

Cyclerion Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-1	0	0	-1	0	0	0	-3	-1
Operating Cash Flow	-1	-1	0	0	0	0	-1	-1	-1
Investing Cash Flow	-	-	-	-	-	-	-	0	0
Financing Cash Flow	-	-	-	1	0	1	0	0	0
Change in Cash	-1	-1	0	0	0	1	-1	0	-1

Cyclerion Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-93	-115	-123	-77	-51	-18	-12	-3	-3
Operating Cash Flow	-81	-97	-102	-72	-36	-40	-21	-4	-3
Investing Cash Flow	-1	-3	-6	0	1	-	10	-	-
Financing Cash Flow	82	100	211	28	30	0	5	-	3
Change in Cash	102	102	102	-44	-4	-40	-5	-4	0

Global Institutional Holdings in Cyclerion Therapeutics

Check out the Institutions with significant holdings in Cyclerion Therapeutics.

Funds	Holdings
Vanguard	0.66%
Fidelity	0.46%
Dimensional	0.13%

Insights on Cyclerion Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 30.4% return, outperforming this stock by 36.3%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 473.5% return, outperforming this stock by 444.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CYCN stock has moved down by -25.7%

About Cyclerion Therapeutics

Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Organisation	Cyclerion Therapeutics
Headquarters	245 First Street, Riverview II, Cambridge, MA, United States, 02142
Industry	Biotechnology
CEO	Dr. Regina M. Graul Ph.D.

Key Management of Cyclerion Therapeutics

Name	Title
Ms. Rhonda M. Chicko CPA	Chief Financial Officer
Dr. Regina M. Graul Ph.D.	CEO, President & Director

FAQs

What is Cyclerion Therapeutics share price today?

Cyclerion Therapeutics share price today is $23.52 as on September 9, 2026 at 8:45 am IST. Cyclerion Therapeutics share today touched a day high of $3.75 and a low of $2.82.

What is the 52 week high and 52 week low for Cyclerion Therapeutics share?

Cyclerion Therapeutics share touched a 52 week high of $8.48 on April 1, 2026 and a 52 week low of $1.03 on February 9, 2026. Cyclerion Therapeutics stock price today i.e. September 9, 2026 at 8:45 am IST is trending at $23.52,which is -177.36% down from its 52 week high and 2191.06% up from its 52 week low.

What is Cyclerion Therapeutics's market capitalisation today?

Cyclerion Therapeutics market capitalisation is $0.00T as on September 9, 2026 at 8:45 am IST.

How to invest in Cyclerion Therapeutics Stock (CYCN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cyclerion Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cyclerion Therapeutics Stock (CYCN) from India?

Indian investors can start investing in Cyclerion Therapeutics (CYCN) shares with as little as ₹94.73999786376953 or $1 (as of November 4, 2026 at 1:07 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Cyclerion Therapeutics stock (as per the Rupee-Dollar exchange rate as on November 4, 2026 at 1:07 am IST). Based on Cyclerion Therapeutics share’s latest price of $23.52 as on September 9, 2026 at 8:45 am IST, you will get 0.4252 shares of Cyclerion Therapeutics. Learn more about fractional shares .

What are the returns that Cyclerion Therapeutics has given to Indian investors in the last 5 years?

Cyclerion Therapeutics stock has given -93.3% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?